Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Alessandra Cesano, Thomas Bachman, and More

Alessandra Cesano

NanoString Technologies has named Alessandra Cesano as chief medical officer. Cesano most recently served as CMO at Cleave Bioscience. Prior to that, she was CMO and chief operations officer at Nodality. She has also held various management positions at Biogen Idec, Amgen, and SmithKline Beecham Pharmaceuticals. Cesano has also served as a visiting professor at the School of Oncology and School of Biotechnology at the University of Turin.

Jinghui Zhang

St. Jude Children's Research Hospital has appointed Jinghui Zhang the first chair of the Department of Computational Biology. Zhang joined St. Jude in 2010, leading the effort to analyze PCGP data and the creation of several new computational tools that have been adopted by biologists worldwide. Prior to her work at St. Jude, she led genetic variation analysis of the first assembled human genome. She also contributed to key discoveries in the pilot phases of the National Cancer Institute's Cancer Genome Atlas Project and the Therapeutically Applicable Research to Generate Effective Treatment initiative.

Thomas Bachman

Eppendorf announced that Thomas Bachman was appointed CEO on August 1, 2015. Bachman is taking over for Detmar Ammerman, who took on the role of CEO in addition to his responsibilities as CFO upon the departure of the previous CEO. Bachman has been a member of Eppendorf's supervisory board since 2013. Before joining Eppendorf, he held a position as president of Burker BioSpin. He has been active in the life science sector since 2005, when he managed the Tecan group, headquartered in Switzerland.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.